Weight gain and hormone replacement therapy: Are women's fears justified?

Maturitas

Volumn 34, Issue SUPPL. 1, 2000, Pages

  Van Seumeren, Ineke ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Body weight; Compliance; Dydrogesterone; Femoston ; Hormone replacement therapy; Menopause; Oestradiol; Weight gain

Indexed keywords

DYDROGESTERONE; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; UNCLASSIFIED DRUG;

BODY FAT; BODY WEIGHT; BREAST CANCER; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; FEAR; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; METABOLIC RATE; PATIENT COMPLIANCE; REHYDRATION; WEIGHT GAIN;

EID: 0033977475     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00073-0     Document Type: Conference Paper

References (24)

1. Pierard-Franchimont C, Letawe C, Goffin V, Pierard GE. Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas 1995;22:151-4.
2. Vaillant L, Callens A. Hormone replacement treatment and skin aging. Therapie 1996;51:67-70.
3. Lapidus L, Bengtsson C, Larsson B, Fennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Brit Med J 1984;289:1257-61.
4. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease, Lancet 1987;821-824.
5. Kannel WB. Epidemiology of essential hypertension: the Framingham experience. Proc R Coll Phys Edin 1991;21:273-87.
6. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham study. Am J Public Health 1988;7:676-9.
7. Despres JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985;34:967-73.
8. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D, Adami HO. Body size in different periods of life and breast cancer risk in postmenopausal women. Int J Cancer 1998;76:29-34.
9. Kumar NB, Lyman GH, Allen K, Cox CE, Schapira DV. Timing of weight gain and breast cancer risk. Cancer 1995;76:243-9.
10. Radimer K, Siskind V, Bain C, Schofield F. Relation between anthropometric indicators and risk of breast cancer among Australian women. Am J Epidemiol 1993;138:77-89.
11. Poehlman ET, Goran MI, Gardner AW, Ades PA, Arciero PJ, Katzman-Rooks SM, Montgomery SM, Toth MJ, Sutherland PT. Determinants of decline in resting metabolic rate in ageing females. Am J Physiol 1993;264:E450-5.
12. Pasquali R, Casimirri F, Labate AM, Tortelli O, Pascal G, Anconetani B, Gatto MR, Flamia R, Capelli M, Barbara L. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord 1994;18:614-21.
13. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 1991;151:97-102.
14. Bjorkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C. Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord 1996;20:213-9.
15. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in bodyfat distribution. Am J Clin Nutr 1992;55:950-4.
16. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, Greendale GA. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997;82:1549-56.
17. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women, J Am Med Assoc 1995;273:199-208.
18. Kritz-Silverstein D, Barrett-Connor E. Long-term post-menopausal hormone use, obesity and fat distribution in older women. J Am Med Assoc 1996;275:46-9.
19. Luoto R, Mannisto S, Vartiainen E. Hormone replacement therapy and body size: how much does lifestyle explain? Am J Obstet Gynecol 1998;178:66-73.
20. Perry AC, Allison M, Applegate EB, Jackson ML, Miller PC. The relationship between fat distribution and coronary risk factors in sedentary postmenopausal women on and off hormone replacement therapy. Obes Res 1998;6:40-6.
21. Foster RH, Balfour JA. Estradiol and dydrogesterone. A review of their combined use as hormonal replacement therapy in postmenopausal women. Drugs Aging 1997;11:309-32.
22. Van der Mooren MJ, Demacker PNM, Thomas CMG, Borm GF, Rolland R. A 2-year study on the beneficial effects of 17β-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone. Eur J Obstet Gynecol Reprod Biol 1993;52:117-23.
23. Hänggi W, Lippuner K, Jaeger P, Birkhäuser MH, Horber FF. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol 1998;48:691-9.
24. Kohrt WM, Ehsani AA, Birge SJ Jr. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program. J Appl Physiol 1998;84:1506-12.